Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NXL | US
0.03
5.45%
Healthcare
Medical Devices
30/06/2024
04/10/2024
0.66
0.70
0.70
0.65
Nexalin Technology Inc. a medical device company designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition it designs and develops Generation 2 and Generation 3 a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate cocaine alcohol abuse Alzheimer's disease and dementia. The company is based in Houston Texas.
View LessPrice Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
64.2%1 month
76.6%3 months
79.5%6 months
248.1%-
-
5.53
-
-
0.02
30.17
-
-6.40M
6.96M
6.96M
-
-4.83K
-
-24.50
-202.23
0.23
0.41
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.15
Range1M
0.44
Range3M
1.04
Rel. volume
0.32
Price X volume
30.11K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
INBS | INBS | Medical Devices | 1.59 | 6.76M | 1.92% | n/a | 10.46% |
Sharps Technology Inc. | STSS | Medical Instruments & Supplies | 0.1524 | 4.36M | -0.78% | n/a | 0.00% |
Predictive Oncology Inc | POAI | Medical Instruments & Supplies | 0.6434 | 4.29M | -11.63% | n/a | 65.94% |
Acutus Medical Inc | AFIB | Medical Devices | 0.122 | 3.65M | 45.24% | n/a | -745.93% |
Common Stock | VERO | Medical Devices | 0.4488 | 3.26M | -12.00% | n/a | 1351.51% |
Talis Biomedical Corporation Common Stock | TLIS | Medical Devices | 1.78 | 3.24M | -6.32% | n/a | 38.66% |
INVO Bioscience Inc | INVO | Medical Devices | 0.7 | 2.73M | 3.55% | 1.03 | 394.32% |
ThermoGenesis Holdings Inc | THMO | Medical Devices | 0.16 | 2.54M | 1.20% | n/a | 776.10% |
NUWE | NUWE | Medical Devices | 1.32 | 2.46M | -10.81% | n/a | -9.57% |
Sintx Technologies Inc | SINT | Medical Devices | 3.23 | 2.41M | 0.94% | n/a | 47.07% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ALBT | ALBT | Real Estate Services | 0.2137 | 3.42M | 6.85% | n/a | 187.39% |
DigitalBridge Group Inc. | DBRG-PJ | Real Estate Services | 25.2 | 0 | 0.20% | n/a | 17.23% |
DigitalBridge Group Inc. | DBRG-PI | Real Estate Services | 25.45 | 0 | 0.24% | n/a | 17.23% |
DigitalBridge Group Inc. | DBRG-PH | Real Estate Services | 25.35 | 0 | 0.00% | n/a | 17.23% |
Common Stock | BPYPO | Real Estate Services | 16.78 | 0 | 0.54% | 7.55 | 866.10% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.02 | 45.99 | Cheaper |
Ent. to Revenue | 30.17 | 13.20 | Expensive |
PE Ratio | - | 29.98 | - |
Price to Book | 5.53 | 6.06 | Par |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 79.45 | 66.08 | Riskier |
Debt to Equity | - | 0.83 | - |
Debt to Assets | - | 0.28 | - |
Market Cap | 6.96M | 9.42B | Emerging |